NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,768 | +75.6% | 144 | +132.3% | 0.00% | – |
| Q2 2023 | $1,576 | -57.3% | 62 | -39.2% | 0.00% | – |
| Q1 2023 | $3,687 | +158.6% | 102 | +183.3% | 0.00% | – |
| Q4 2022 | $1,426 | -89.0% | 36 | -86.8% | 0.00% | – |
| Q3 2022 | $13,000 | +225.0% | 272 | +235.8% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 81 | -35.7% | 0.00% | – |
| Q1 2022 | $9,000 | -77.5% | 126 | -74.7% | 0.00% | -100.0% |
| Q4 2021 | $40,000 | +3900.0% | 499 | +7028.6% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 7 | -36.4% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 11 | +120.0% | 0.00% | – |
| Q3 2020 | $1,000 | -87.5% | 5 | -93.2% | 0.00% | -100.0% |
| Q3 2016 | $8,000 | – | 74 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |